CD68 and neoplasm: Future studies should examine whether CSF1/CSF1R acts synergistically with CD4+ Th1 cells to activate anti-tumor CD68+ macrophages, or adaptive CSF1 secretion upon exposure to CD4+ T cell-derived cytokines act detrimentally to recruit M2-like TAMs and consequently hamper antitumor immune responses.